TFAP2A and colorectal cancer: TFAP2A acts as a potential transcription factor for some members of the ECM receptors and integrin subunit beta (ITGB) superfamily, potentially activating the signaling pathways of oncogenesis, ECM remodeling, EMT process, and immunosuppressive immune cell accumulation in pancreatic and colorectal cancer [73, 74].